Literature DB >> 21282828

Reversible posterior leukoencephalopathy syndrome in Chinese children induced by chemotherapy: a review of five cases.

K M Belaramani1, V Lai, C H Li, A C W Lee, N S Kwong.   

Abstract

This is a retrospective review of the clinico-radiological features and neurological outcomes of reversible posterior leukoencephalopathy syndrome episodes in Chinese cancer children receiving chemotherapy in a regional hospital in Hong Kong from 1998 to 2008. Five children (3 males and 2 females) with a mean age of 7 years were identified, four of whom had acute lymphoblastic leukaemia and one had a central nervous system germ cell tumour. Presenting symptoms included seizures (100%), altered mental function (100%), headache (40%), and visual disturbance (60%). The mean systolic blood pressure at presentation was 158 mm Hg. Approximately 80% had typical radiological features of reversible posterior leukoencephalopathy syndrome. All showed complete recovery after the acute stage, but one subsequently developed epilepsy. Two patients ultimately died of refractory malignant disease. Two others were followed up for a mean of 6 years, and remained neurologically normal. This report was the first case review documenting reversible posterior leukoencephalopathy syndrome in Chinese cancer children. The clinico-radiological features and neurological outcomes were similar to those reported in western series. Early recognition of the syndrome is important to facilitate appropriate treatment. The central nervous system damage may not be reversible and thus long-term follow-up is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282828

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  4 in total

1.  Different Clinicoradiological Characteristics of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncology and Post-Bone Marrow Transplantation Cases: A Retrospective Study.

Authors:  Hwazen Shash; Saad Aldaama; Hala Omer; Sameera Alafghani
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

2.  Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.

Authors:  Narimane Salmi; Ibrahim Elghissassi; Khadija Bellahammou; Asmaa Lakhdissi; Hind Mrabti; Hassan Errihani
Journal:  Case Rep Oncol Med       Date:  2014-10-21

3.  Posterior Reversible Encephalopathy Syndrome in ALL.

Authors:  J Gordon Millichap
Journal:  Pediatr Neurol Briefs       Date:  2015-07

4.  PRES in the course of hemato-oncological treatment in children.

Authors:  Katarzyna Musioł; Sylwia Waz; Michał Boroń; Magdalena Kwiatek; Magdalena Machnikowska-Sokołowska; Katarzyna Gruszczyńska; Grażyna Sobol-Milejska
Journal:  Childs Nerv Syst       Date:  2017-12-02       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.